查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916863

心臟超音波設備市場按系統類型、模式、應用和最終用戶分類 - 全球預測 2026-2032 年

Cardiac Ultrasound Equipment Market by System Type, Modality, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心臟超音波設備市場價值將達到 25.6 億美元，到 2026 年將成長至 27 億美元，到 2032 年將達到 38.7 億美元，複合年成長率為 6.05%。

關鍵市場統計數據
基準年 2025 25.6億美元
預計年份：2026年 27億美元
預測年份 2032 38.7億美元
複合年成長率 (%) 6.05%

隨著臨床和採購環境的變化，技術複雜性、便攜性和互通性正在推動心臟超音波。

在技​​術進步、臨床重點轉變以及醫療系統採購慣例演變的共同推動下，心臟超音波設備市場正處於轉折點。影像處理的進步正在拓展超音波的應用範圍，使其涵蓋術中、經食道和經胸等多種應用，而系統外形規格也從推車式主機到高度便攜的筆記型電腦和手持設備，種類繁多。同時，醫療服務模式正日益重視照護現場診斷和門診手術，這正在重塑採購標準和臨床工作流程。

人工智慧成像、攜帶式外形規格和整合服務模式的融合正在重塑臨床工作流程和照護端的供應商差異化。

隨著影像技術與以工作流程為中心的設計和分散式醫療模式的融合，醫療保健環境正在經歷變革性變化。首先，電腦輔助成像和人工智慧輔助分析已從實驗階段發展成為嵌入式臨床工具，能夠提高操作者的操作水平並降低測量誤差。這些進步在操作者經驗水平參差不齊的環境中尤其重要，使更多不同經驗水平的臨床醫生能夠進行一致的心臟評估。

到 2025 年，關稅主導的供應鏈重組正在加速採購多元化、在地化進程，並更加重視供應商的韌性。

美國在2025年前實施的政策調整和關稅措施，給全球醫療影像硬體供應鏈帶來了巨大壓力。影響零件和成品的關稅加劇了依賴跨境採購專用超音波換能器、半導體和精密機械零件的製造商的成本壓力。因此，供應商正透過多元化供應鏈網路、加快關鍵子組件的在地化生產以及協商修訂商業條款來應對，以維持利潤率並為醫療服務提供者提供具有競爭力的價格。

設備的選擇受多種因素驅動，包括系統外形規格、成像方式能力、臨床應用要求和最終用戶操作限制。

心臟超音波設備的差異在按系統類型、影像模式、臨床應用和最終用戶環境進行評估時最為明顯。系統分為主機和可攜式兩類，可攜式平台可細分為筆記型電腦和手持式。這種分類影響著影像功能、人體工學和臨床工作流程中的操作便利性的選擇。成像模式的差異，例如2D、3D/四維成像和多普勒功能（多普勒模式包括彩色多普勒、連續波和脈衝波技術），決定了診斷範圍，並影響探頭和軟體的選擇。這些影像模式的差異最終體現在瓣膜評估、血流定量和結構視覺化等臨床效用的差異。

區域部署模式和採購慣例差異很大，要求供應商調整產品系列、服務模式和培訓投資，以滿足當地需求。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的技術採納、採購偏好和供應商策略有顯著影響。在美洲，大規模綜合醫療系統和門診網路優先考慮互通性、供應商服務覆蓋範圍以及支援高容量影像工作流程的解決方案，而私人診斷中心則傾向於尋求經濟高效、可攜式的系統來擴展照護現場能力。在歐洲、中東和非洲地區，監管協調、多樣化的報銷環境以及國家採購框架的存在影響採購時間表，使得那些能夠證明自身合規性並具備在多個國家提供服務能力的供應商更受青睞。

競爭優勢日益源自於整合硬體、檢驗的軟體、全面的服務產品以及可擴展的臨床培訓計畫。

心臟超音波設備的競爭格局由那些將成像硬體技術與強大的軟體生態系統、服務網路和臨床培訓項目相結合的公司所主導。市場領導者優先投資於探頭設計、影像處理演算法和工作流程整合，以確保在術中、經食道和經胸應用中提供經臨床檢驗的性能。同時，一些專業化和新興供應商則專注於便攜性、創新外形規格和基於訂閱的軟體服務，以降低門診手術中心和診斷機構的准入門檻。

協調產品設計、臨床檢驗、供應鏈韌性和以結果為導向的服務，以滿足臨床效用和營運效率相結合的需求。

產業領導者應優先考慮整合產品開發、臨床檢驗和服務交付的策略，以滿足醫療服務提供者不斷變化的需求。首先，投資於以用戶為中心的設計和人工智慧增強的成像功能，將提高診斷的一致性，同時降低對操作人員的依賴性，從而促進更廣泛的終端用戶群採用臨床應用。其次，制定可攜式組合細分策略，將主機、筆記型電腦級攜帶式設備和手持設備明確分類到特定的臨床應用場景中，將使銷售團隊能夠提供針對門診、診斷和住院環境最佳化的、極具吸引力的價值提案。

一項透明的多來源調查方法結合了對臨床醫生和採購負責人的訪談以及技術和區域文獻，以確保研究結果的可重複性。

本分析整合了多方面的調查方法，結合了對臨床醫生、採購人員和供應商高管的訪談，以及對監管申報文件、設備技術文件和同行評審臨床文獻的二次審查。透過結構化訪談收集質性見解，訪談內容檢驗門診手術中心、診斷中心和醫院環境中的採購標準、臨床工作流程和實施後支援經驗。二級資訊來源提供了有關成像方式、感測器創新和軟體整合模式的技術背景。

檢驗的成像性能與切實可行的服務交付和具有彈性的供應鏈相結合的供應商，將帶來持續的臨床影響。

心臟超音波設備正步入一個新時代，其特點是臨床應用更加便捷、成像能力更強，以及對服務和供應鏈穩健性的日益重視。人工智慧、探頭設計和系統小型化等方面的技術進步，正在拓展心臟超音波在術中、經食道和經胸等臨床應用中的效用。同時，終端用戶偏好越來越傾向選擇部署迅速、操作直覺、IT整合無縫銜接的解決方案。此外，政策措施和關稅調整也進一步凸顯了供應鏈多元化和合約透明度的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依系統類型分類的心臟超音波設備市場

  • 主機類型
  • 可攜式的
    • 手持式
    • 筆記型電腦

9. 按模式分類的心臟超音波設備市場

  • 2D
  • 3D/4D
  • 多普勒
    • 彩色多普勒
    • 連續波多普勒
    • 脈衝波多普勒

第10章：按應用分類的心臟超音波設備市場

  • 術中超音波檢查
  • 經食道心臟心臟超音波圖
  • 胸前心臟超音波

第11章：依最終用戶分類的心臟超音波設備市場

  • 門診手術中心
  • 診斷中心
  • 醫院

第12章：按地區分類的心臟超音波設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：心臟超音波設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：各國心臟超音波設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國心臟超音波設備市場

第16章：中國心臟超音波設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Butterfly Network, Inc.
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare Technologies, Inc.
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Trivitron Healthcare
  • Vave Health
Product Code: MRR-AE420CB153BA

The Cardiac Ultrasound Equipment Market was valued at USD 2.56 billion in 2025 and is projected to grow to USD 2.70 billion in 2026, with a CAGR of 6.05%, reaching USD 3.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.56 billion
Estimated Year [2026] USD 2.70 billion
Forecast Year [2032] USD 3.87 billion
CAGR (%) 6.05%

An evolving clinical and procurement environment is redefining the role of cardiac ultrasound with technological refinement, portability, and interoperability driving adoption

The cardiac ultrasound equipment landscape is at an inflection point driven by technological refinement, shifting clinical priorities, and evolving procurement practices across healthcare systems. Advances in image processing, miniaturization, and probe technology are expanding the role of ultrasound across intraoperative, transesophageal, and transthoracic applications, while system form factors range from cart-based consoles to highly portable laptop and handheld devices. In parallel, healthcare delivery models emphasize point-of-care diagnostics and outpatient procedural settings, which is reshaping purchasing criteria and clinical workflows.

Clinicians and hospital administrators increasingly prioritize diagnostic clarity, ease of use, and interoperability with electronic health records, prompting suppliers to focus on software-driven enhancements and service offerings. Regulatory expectations and reimbursement dynamics also converge to influence adoption pathways, and procurement teams are weighing lifecycle costs, training requirements, and service coverage alongside capital pricing. Taken together, these dynamics create a competitive environment where technology differentiation, clinical validation, and strategic partnerships determine which vendors and solutions rise to prominence.

Convergence of AI-enabled imaging, portable form factors, and integrated service models is reshaping clinical workflows and vendor differentiation across care settings

The landscape is undergoing transformative shifts as imaging capability converges with workflow-centric design and distributed care models. First, computational imaging and AI-assisted interpretation are moving beyond experimental phases into embedded clinical tools that augment operator performance and reduce variability in measurements. These developments are particularly consequential in settings where operator experience varies, enabling more consistent cardiac function assessment across a broader pool of clinicians.

Second, portability and form factor innovation are altering where and how echocardiography is delivered, extending point-of-care diagnostics into ambulatory surgical centers and procedural suites. Third, software ecosystems and cloud-enabled platforms are enabling secure image sharing and remote consultations, which enhance multidisciplinary review and support tele-echocardiography pathways. Finally, strategic alignment between vendors and health systems through service bundles, training programs, and outcome-based contracting is becoming a differentiator. Together, these forces create an environment in which user-centered design, clinical validation, and scalable service models determine long-term competitive advantage.

Tariff-driven supply chain reconfiguration through 2025 has intensified sourcing diversification, localization efforts, and procurement emphasis on supplier resilience

Policy shifts and tariff actions implemented by the United States through 2025 have exerted measurable pressure on global supply chains for medical imaging hardware. Tariff measures affecting components and finished goods have increased cost pressures for manufacturers that rely on cross-border sourcing of specialized ultrasound transducers, semiconductors, and precision mechanical parts. As a result, suppliers have responded by diversifying supplier networks, accelerating localization of critical subassemblies, and negotiating revised commercial terms to preserve margin and maintain competitive pricing for healthcare providers.

These adjustments have not been uniform across the value chain. Large OEMs with global manufacturing footprints have been better positioned to absorb incremental duties through supply chain optimization and hedged purchasing, while smaller specialized suppliers have faced tighter margin compression and longer lead times as they reconfigure production footprints. Clinicians and procurement teams have observed an intermittent cadence of component shortages and extended delivery windows, prompting hospitals and diagnostic centers to emphasize supplier resilience and contractual assurances in purchasing processes. In response, several manufacturers have introduced inventory financing and extended warranty options to mitigate short-term procurement risk and ensure continuity of clinical services.

Device choice hinges on a layered set of criteria spanning system form factor, imaging modality capabilities, clinical application demands, and distinct end-user operational constraints

Differentiation across cardiac ultrasound equipment appears most pronounced when devices are assessed by system type, modality, clinical application, and end-user setting. Systems fall into console and portable classes, with portable platforms further subdivided into laptop-style and handheld devices; this division informs choices about imaging capability, ergonomics, and mobility within clinical workflows. Modality distinctions between 2D, 3D/4D, and Doppler functionality, with Doppler modalities including color Doppler, continuous wave, and pulse wave techniques, shape the diagnostic scope and influence the selection of transducers and software packages. These modality differences translate into varied clinical utility for valve assessment, quantification of flow, and structural visualization.

Application-specific requirements further refine device selection across intraoperative echocardiography, transesophageal echocardiography, and transthoracic echocardiography, as each use case imposes different constraints on probe design, sterility protocols, and image acquisition speed. Finally, end-user environments such as ambulatory surgical centers, diagnostic centers, and hospitals have distinct space, staffing, and throughput needs that dictate preferences for compact, rapidly deployable systems or comprehensive console platforms with advanced post-processing capabilities. By considering system type, modality, application, and end-user context together, stakeholders can align procurement and clinical training to maximize clinical value and operational efficiency.

Regional adoption patterns and procurement practices vary widely, requiring vendors to tailor product portfolios, service models, and training investments to local needs

Regional dynamics exert a powerful influence on technology adoption, procurement preferences, and vendor strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, large integrated healthcare systems and ambulatory networks prioritize interoperability, vendor service coverage, and solutions that support high-volume imaging workflows, while private diagnostic centers often seek cost-effective portable systems to expand point-of-care capabilities. Across Europe, Middle East & Africa, regulatory harmonization, varied reimbursement environments, and the presence of national procurement frameworks shape procurement timelines and favor vendors who demonstrate compliance and multi-country service capability.

In the Asia-Pacific region, rapid investment in healthcare infrastructure, growing outpatient procedural volumes, and emphasis on scalable training programs drive demand for portable platforms and localized service models. Differences in capital cycle length, labor availability, and clinical training also affect adoption curves, creating opportunities for vendors that offer comprehensive education packages, flexible financing, and partnerships with local distributors. Taken together, these regional distinctions necessitate tailored commercialization strategies that align product portfolios, service models, and training investments with the unique demands of each geography.

Competitive advantage is increasingly derived from integrated hardware, validated software, comprehensive service delivery, and scalable clinical training programs

Competitive dynamics in cardiac ultrasound equipment are shaped by firms that combine imaging hardware expertise with robust software ecosystems, service networks, and clinical training programs. Market leaders have prioritized investments in probe design, image processing algorithms, and workflow integration to deliver clinically validated performance across intraoperative, transesophageal, and transthoracic applications. At the same time, a cohort of specialist and emerging vendors focuses on portability, disruptive form factors, and subscription-based software services that lower entry barriers for ambulatory surgical centers and diagnostic facilities.

Supplier strategies increasingly emphasize bundled offerings that include extended warranties, operator training, remote diagnostics, and software updates delivered through secure cloud platforms. Partnerships between imaging manufacturers and third-party clinical workflow vendors are accelerating interoperability and integration with hospital IT systems. For health systems, vendor evaluation now encompasses not only technical performance but also the depth of clinical evidence, training infrastructure, and the reliability of aftermarket support. These competitive factors are defining the contours of supplier selection and long-term vendor relationships.

Align product design, clinical validation, supply resilience, and outcome-focused services to capture demand where clinical utility and operational efficiency intersect

Industry leaders should prioritize cohesive strategies that align product development, clinical validation, and service delivery to meet evolving provider needs. First, investing in user-centered design and AI-augmented imaging features will improve diagnostic consistency while reducing operator dependence, thereby increasing clinical uptake across a broader set of end users. Second, developing a clear portfolio segmentation that maps consoles, laptop-class portables, and handheld devices to specific clinical use cases will help sales teams present compelling value propositions tailored to ambulatory, diagnostic, and hospital settings.

Third, strengthening supply chain resilience through diversified sourcing, regional manufacturing partnerships, and transparent lead-time commitments will reduce procurement friction and support longer-term contracts. Fourth, expanding service models to include bundled training, remote troubleshooting, and outcome-oriented support will enhance customer retention and justify premium pricing. Finally, forging collaborative relationships with clinical champions, academic centers, and technology partners will accelerate evidence generation and facilitate smoother clinical adoption pathways. Executing on these priorities will position firms to capture demand where clinical utility, operational efficiency, and vendor reliability converge.

A transparent, multi-source research approach combined primary clinician and procurement interviews with technical literature and regional documentation to ensure reproducibility

This analysis synthesizes a multi-source research approach combining primary interviews with clinicians, procurement leaders, and supplier executives along with secondary review of regulatory filings, device technical documentation, and peer-reviewed clinical literature. Qualitative insights were collected through structured interviews that examined procurement criteria, clinical workflows, and post-deployment support experiences across ambulatory surgical centers, diagnostic centers, and hospital environments. Secondary sources provided technical context on imaging modalities, transducer innovations, and software integration patterns.

Data integrity was maintained through triangulation across sources and cross-validation with product specifications and published clinical studies. Regional perspectives were captured through interviews and localized documentation to account for differing regulatory frameworks and procurement models across the Americas, Europe, Middle East & Africa, and Asia-Pacific. The methodology prioritized reproducibility and transparency by documenting interview protocols, inclusion criteria for secondary sources, and the analytical frameworks used to interpret modality-, application-, and end-user-specific dynamics.

Sustained clinical impact will accrue to vendors who pair validated imaging performance with operationally practical service offerings and resilient supply chains

Cardiac ultrasound equipment is entering a new era characterized by greater clinical accessibility, enhanced imaging capability, and intensifying emphasis on service and supply chain robustness. Technological advances in AI, probe design, and system miniaturization are expanding clinical utility across intraoperative, transesophageal, and transthoracic use cases, while end-user preferences are shifting toward solutions that deliver rapid deployment, intuitive operation, and seamless IT integration. Meanwhile, policy actions and tariff changes have reinforced the importance of supply chain diversification and contractual clarity.

For healthcare organizations and suppliers alike, the path forward requires balancing clinical performance with operational practicality: devices must not only deliver high-quality images but also fit within staffing models, cleaning and sterility protocols, and electronic health record workflows. Those vendors that marry validated imaging performance with comprehensive training, resilient logistics, and outcome-oriented service offerings will be best positioned to build durable partnerships with health systems and diagnostic providers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Ultrasound Equipment Market, by System Type

  • 8.1. Console
  • 8.2. Portable
    • 8.2.1. Handheld
    • 8.2.2. Laptop

9. Cardiac Ultrasound Equipment Market, by Modality

  • 9.1. 2D
  • 9.2. 3D/4D
  • 9.3. Doppler
    • 9.3.1. Color Doppler
    • 9.3.2. Continuous Wave Doppler
    • 9.3.3. Pulse Wave Doppler

10. Cardiac Ultrasound Equipment Market, by Application

  • 10.1. Intraoperative Echocardiography
  • 10.2. Transesophageal Echocardiography
  • 10.3. Transthoracic Echocardiography

11. Cardiac Ultrasound Equipment Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Cardiac Ultrasound Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cardiac Ultrasound Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cardiac Ultrasound Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cardiac Ultrasound Equipment Market

16. China Cardiac Ultrasound Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Butterfly Network, Inc.
  • 17.6. Canon Medical Systems Corporation
  • 17.7. Esaote S.p.A.
  • 17.8. Fujifilm Holdings Corporation
  • 17.9. GE Healthcare Technologies, Inc.
  • 17.10. Hitachi, Ltd.
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Samsung Medison Co., Ltd.
  • 17.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.14. Siemens Healthineers AG
  • 17.15. Trivitron Healthcare
  • 17.16. Vave Health

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY CONSOLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY CONSOLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY CONSOLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY LAPTOP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY LAPTOP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY LAPTOP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY 2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY 2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY 2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY 3D/4D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY 3D/4D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY 3D/4D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COLOR DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COLOR DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COLOR DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY CONTINUOUS WAVE DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY CONTINUOUS WAVE DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY CONTINUOUS WAVE DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PULSE WAVE DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PULSE WAVE DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PULSE WAVE DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE ECHOCARDIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE ECHOCARDIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE ECHOCARDIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY TRANSTHORACIC ECHOCARDIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY TRANSTHORACIC ECHOCARDIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY TRANSTHORACIC ECHOCARDIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CARDIAC ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)